Galapagos | GLPG - Loan Capital

Stock Price
28.24
Daily Change
-0.36 -1.26%
Monthly
0.71%
Yearly
27.90%
Q1 Forecast
27.75

Galapagos reported EUR5.76M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 6.55B 19.43B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
Genmab DKK 126M 6M Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 9.09B 1.64B Sep/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Incyte USD 35.37M 3.61M Sep/2025
Merck EUR 10.45B 4.15B Sep/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Novartis USD 24.24B 174M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
UCB EUR 2.82B 146M Jun/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025